TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Click for best price
| Market size in 2024 | US$ 28.6 million |
Forecast Market size by 2030 | US$ 76.4 million |
|---|---|---|---|
| Growth Rate | CAGR of 17.8% | Number of Pages | 205 Pages |
Russia CAR T-Cell Therapy market was valued at US$ 28.6 million in 2024 and is projected to reach US$ 76.4 million by 2030, at a CAGR of 17.8% during the forecast period 2024-2030.
Immunotherapy that uses genetically modified T cells to target and fight certain types of cancer.
Rapid growth driven by increasing adoption in treating certain blood cancers. Ongoing research and clinical trials expanding potential applications. High cost of therapy and limited availability currently constraining market size.
This report contains market size and forecasts of CAR T-Cell Therapy in Russia, including the following market information:
• Russia CAR T-Cell Therapy Market Revenue, 2019-2024, 2024-2030, ($ millions)
• Russia CAR T-Cell Therapy Market Sales, 2019-2024, 2024-2030,
• Russia Top five CAR T-Cell Therapy companies in 2023 (%)
Report Includes
This report presents an overview of Russia market for CAR T-Cell Therapy , sales, revenue and price. Analyses of the Russia market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report focuses on the CAR T-Cell Therapy sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the Russia CAR T-Cell Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues.
This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Sales Channels, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Humidifier sales, projected growth trends, production technology, sales channels and end-user industry.
• Axicabtagene Ciloleucel (Yescarta)
• Tisagenlecleucel (Kymriah)
• Ciltacabtagene Autoleucel (Carvykti)
• Brexucabtagene Autoleucel (Tecartus)
• Lisocabtagene Maraleucel (Breyanzi)
• Leukemia
• Lymphoma
• Multiple Myeloma
• Others
Key Companies covered in this report:
• Pharmstandard
• Biocad
• R-Pharm
• Generium
• OncoTartis
• HemaCore
• Cell Therapies
• Company 8
• Company 9
• Company 10
Including or excluding key companies relevant to your analysis.
The report also provides analysis of leading market participants including:
• Key companies CAR T-Cell Therapy revenues in Russian market, 2019-2024 (Estimated), ($ millions)
• Key companies CAR T-Cell Therapy revenues share in Russian market, 2023 (%)
• Key companies CAR T-Cell Therapy sales in Russian market, 2019-2024 (Estimated),
• Key companies CAR T-Cell Therapy sales share in Russian market, 2023 (%)
Key Indicators Analysed
• Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2019-2030 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
• Russian Market Analysis: The report includes Russian market status and outlook 2019-2030. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
• Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
• Opportunities and Drivers: Identifying the Growing Demands and New Technology
• Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the CAR T-Cell Therapy Market
• Overview of the regional outlook of the CAR T-Cell Therapy Market
Key Reasons to Buy this Report:
• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
We offer additional regional and global reports that are similar:
• Global CAR T-Cell Therapy Market
• United States CAR T-Cell Therapy Market
• Japan CAR T-Cell Therapy Market
• Germany CAR T-Cell Therapy Market
• South Korea CAR T-Cell Therapy Market
• Indonesia CAR T-Cell Therapy Market
• Brazil CAR T-Cell Therapy Market
Customization of the Report: In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are meet.
| Report Attributes | Report Details |
|---|---|
| Report Title | Russia CAR T-Cell Therapy Market |
| Market size in 2024 | US$ 28.6 million |
| Forecast Market size by 2030 | US$ 76.4 million |
| Growth Rate | CAGR of 17.8% |
| Historical Year | 2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year | 2023 |
| Forecast Year | 2031 |
| Number of Pages | 205 Pages |
| Customization Available | Yes, the report can be customized as per your need. |
1.1 CAR T-Cell Therapy Product Introduction
1.2.1 Russian CAR T-Cell Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Axicabtagene Ciloleucel (Yescarta)
1.2.3 Tisagenlecleucel (Kymriah)
1.2.4 Ciltacabtagene Autoleucel (Carvykti)
1.2.5 Brexucabtagene Autoleucel (Tecartus)
1.2.6 Lisocabtagene Maraleucel (Breyanzi)
1.3.1 Russia CAR T-Cell Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Leukemia
1.3.3 Lymphoma
1.3.4 Multiple Myeloma
1.3.5 Others
1.4 Russia CAR T-Cell Therapy Sales Estimates and Forecasts 2019-2030
1.5 Russia CAR T-Cell Therapy Hydrocephalus Shunts Revenue Estimates and Forecasts 2019-2030
1.6 Study Objectives
1.7 Years Considered
2.1 Russia CAR T-Cell Therapy Sales by Manufacturers
2.1.1 Russia CAR T-Cell Therapy Sales by Manufacturers (2019-2024)
2.1.2 Russia CAR T-Cell Therapy Sales Market Share by Manufacturers (2019-2024)
2.1.3 Top Largest Manufacturers of CAR T-Cell Therapy in 2023 in Russia
2.2 Russia CAR T-Cell Therapy Revenue by Manufacturers
2.2.1 Russia CAR T-Cell Therapy Revenue by Manufacturers (2019-2024)
2.2.2 Russia CAR T-Cell Therapy Revenue Market Share by Manufacturers (2019-2024)
2.2.3 Russia Top Companies by CAR T-Cell Therapy Revenue in 2023
2.3 Russia CAR T-Cell Therapy Sales Price by Manufacturers (2019-2024)
2.4 Analysis of Competitive Landscape
2.4.1 Manufacturers Market Concentration Ratio (CR3 and HHI)
2.4.2 Russia CAR T-Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
2.4.3 Russia CAR T-Cell Therapy Manufacturers Geographical Distribution
2.5 Mergers & Acquisitions, Expansion Plans
3.1 CAR T-Cell Therapy Market Size by Region: 2019-2030
3.1.1 Russia CAR T-Cell Therapy Sales by Region: 2019-2024
3.1.2 Russia CAR T-Cell Therapy Sales Forecast by Region (2025-2030)
3.1.3 Russia CAR T-Cell Therapy Revenue by Region: 2019-2024
3.1.4 Russia CAR T-Cell Therapy Revenue Forecast by Region (2025-2030)
4.1 Russia CAR T-Cell Therapy Sales by Type
4.1.1 Russia CAR T-Cell Therapy Historical Sales by Type (2019-2024)
4.1.2 Russia CAR T-Cell Therapy Forecasted Sales by Type (2025-2030)
4.1.3 Russia CAR T-Cell Therapy Sales Market Share by Type (2019-2030)
4.2 Russia CAR T-Cell Therapy Revenue by Type
4.2.1 Russia CAR T-Cell Therapy Historical Revenue by Type (2019-2024)
4.2.2 Russia CAR T-Cell Therapy Forecasted Revenue by Type (2025-2030)
4.2.3 Russia CAR T-Cell Therapy Revenue Market Share by Type (2019-2030)
4.3 Russia CAR T-Cell Therapy Price by Type
4.3.1 Russia CAR T-Cell Therapy Price by Type (2019-2024)
4.3.2 Russia CAR T-Cell Therapy Price Forecast by Type (2025-2030)
5.1 Russia CAR T-Cell Therapy Sales by Application
5.1.1 Russia CAR T-Cell Therapy Historical Sales by Application (2019-2024)
5.1.2 Russia CAR T-Cell Therapy Forecasted Sales by Application (2025-2030)
5.1.3 Russia CAR T-Cell Therapy Sales Market Share by Application (2019-2030)
5.2 Russia CAR T-Cell Therapy Revenue by Application
5.2.1 Russia CAR T-Cell Therapy Historical Revenue by Application (2019-2024)
5.2.2 Russia CAR T-Cell Therapy Forecasted Revenue by Application (2025-2030)
5.2.3 Russia CAR T-Cell Therapy Revenue Market Share by Application (2019-2030)
5.3 Russia CAR T-Cell Therapy Price by Application
5.3.1 Russia CAR T-Cell Therapy Price by Application (2019-2024)
5.3.2 Russia CAR T-Cell Therapy Price Forecast by Application (2025-2030)
6.1 Pharmstandard
6.1.1 Pharmstandard Corporation Information
6.1.2 Pharmstandard Overview
6.1.3 Pharmstandard in Russia: CAR T-Cell Therapy Sales, Price, Revenue and Gross Margin (2019-2024)
6.1.4 Pharmstandard CAR T-Cell Therapy Product Introduction
6.1.5 Pharmstandard Recent Developments
6.2 Biocad
6.2.1 Biocad Corporation Information
6.2.2 Biocad Overview
6.2.3 Biocad in Russia: CAR T-Cell Therapy Sales, Price, Revenue and Gross Margin (2019-2024)
6.2.4 Biocad CAR T-Cell Therapy Product Introduction
6.2.5 Biocad Recent Developments
6.3 R-Pharm
6.3.1 R-Pharm Corporation Information
6.3.2 R-Pharm Overview
6.3.3 R-Pharm in Russia: CAR T-Cell Therapy Sales, Price, Revenue and Gross Margin (2019-2024)
6.3.4 R-Pharm CAR T-Cell Therapy Product Introduction
6.3.5 R-Pharm Recent Developments
6.4 Generium
6.4.1 Generium Corporation Information
6.4.2 Generium Overview
6.4.3 Generium in Russia: CAR T-Cell Therapy Sales, Price, Revenue and Gross Margin (2019-2024)
6.4.4 Generium CAR T-Cell Therapy Product Introduction
6.4.5 Generium Recent Developments
6.5 OncoTartis
6.5.1 OncoTartis Corporation Information
6.5.2 OncoTartis Overview
6.5.3 OncoTartis in Russia: CAR T-Cell Therapy Sales, Price, Revenue and Gross Margin (2019-2024)
6.5.4 OncoTartis CAR T-Cell Therapy Product Introduction
6.5.5 OncoTartis Recent Developments
6.6 HemaCore
6.6.1 HemaCore Corporation Information
6.6.2 HemaCore Overview
6.6.3 HemaCore in Russia: CAR T-Cell Therapy Sales, Price, Revenue and Gross Margin (2019-2024)
6.6.4 HemaCore CAR T-Cell Therapy Product Introduction
6.6.5 HemaCore Recent Developments
6.7 Cell Therapies
6.7.1 Cell Therapies Corporation Information
6.7.2 Cell Therapies Overview
6.7.3 Cell Therapies in Russia: CAR T-Cell Therapy Sales, Price, Revenue and Gross Margin (2019-2024)
6.7.4 Cell Therapies CAR T-Cell Therapy Product Introduction
6.7.5 Cell Therapies Recent Developments
7.1 CAR T-Cell Therapy Industry Chain Analysis
7.2 CAR T-Cell Therapy Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 CAR T-Cell Therapy Production Mode & Process
7.4 CAR T-Cell Therapy Sales and Marketing
7.4.1 CAR T-Cell Therapy Sales Channels
7.4.2 CAR T-Cell Therapy Distributors
7.5 CAR T-Cell Therapy Customers
8.1.1 CAR T-Cell Therapy Industry Trends
8.1.2 CAR T-Cell Therapy Market Drivers
8.1.3 CAR T-Cell Therapy Market Challenges
8.1.4 CAR T-Cell Therapy Market Restraints
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Frequently Asked Questions ?
